glg-v 13 has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berlin, KD; Garrison, GL; Lazzara, R; Patterson, E; Scherlag, BJ | 1 |
| Berlin, KD; Chen, CL; Fazekas, T; Garrison, GL; Lazzara, R; Patterson, E; Sangiah, S; Scherlag, BJ; Schubot, FD; van der Helm, D | 1 |
2 other study(ies) available for glg-v 13 and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Electrophysiologic actions of d,l-sotalol and GLG-V-13 in ischemically injured canine epicardium.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Bridged Bicyclo Compounds, Heterocyclic; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Electrophysiology; Heart Conduction System; Imidazoles; Ligation; Male; Myocardial Ischemia; Pericardium; Sotalol; Tachycardia, Ventricular | 2007 |
Novel 3,7-diheterabicyclo[3.3.1]nonanes that possess predominant class III antiarrhythmic activity in 1-4 day post infarction dog models: X-ray diffraction analysis of 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3,7-diazabicyclo[3.3.1]nona ne dihydroperch
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Crystallography, X-Ray; Dogs; Electrophysiology; Heart Rate; Imidazoles; Lidocaine; Models, Molecular; Molecular Conformation; Molecular Structure; Myocardial Infarction; Tachycardia, Ventricular | 1996 |